Pier Capital’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Pier Capital's IONS Position: Q3 2026 in Review
Pier Capital opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 69,240 shares worth $3.09M. The stake represents 0.45% of the portfolio and ranks #93 among its holdings.
464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Pier Capital held 69,240 shares of Ionis Pharmaceuticals worth $3.09M as of Q3 2026.
- Ionis Pharmaceuticals was a new Pier Capital position in Q3 2026.
- Ionis Pharmaceuticals made up 0.45% of Pier Capital's portfolio in Q3 2026, its #93 holding.
- 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Pier Capital's 13F filing for Q3 2026, filed 13 Nov 2026.